About Us

We are a team of award-winning scientists with a mission to empower individuals to make better-informed decisions about their skin health.

Sequential Skin is the result of the founders’ passion for molecular genetics.

Sequential Skin was born from scientific research and discovery for the purpose of bettering people’s chances of having healthy skin without going through the trial and error process of discovering what their skin’s needs truly are.

We have spent years developing the most innovative adhesive patch to collect skin samples that can be analyzed most effectively.

Leadership

Our microbiome test is the most comprehensive test on the market. We use a method known as quantitative real-time PCR (qPCR) that looks at specific markers in your skin microbiome and how they impact your skin. Our microbiome markers were generated in an ISO 13485 (medical devices) and CAP-accredited lab, ensuring our results' quality, accuracy, and reliability.

Every single one of the samples that we receive is studied in our lab at the hands of the industry’s top scientific minds and is handled with care and the utmost discretion. Based on the analysis, a comprehensive report is compiled and shared with the hope to introduce skincare beyond you and what the eye can see.

Dr. Oliver Worsley

CEO & CO-FOUNDER

Dr. Albert Dashi

CHIEF SCIENCE OFFICER & CO-FOUNDER

Petronille Houdart, PharmD

SKINCARE DIRECTOR

Trusted by dermatologists

Sequential Skin’s test is to pioneer a next-generation skin microbiome test to be able to help with identification, analysis and early-stratification of the skin microbiome. It’s known the skin microbiome is dysbalanced in certain people, and so understanding the progression of skin microbiome colonization between healthy skin and skin traits is paramount.

Further research and studies in the skin microbiome field is much needed and the Sequential Skin team is pivotal in this respect. The team is interrogating the skin microbiome for its potential to find new ways to improve the health of the skin.

DR NATALYA FOX, DERMATOLOGIST,

NHS (EPSOM AND ST HELIER UNIVERSITY HOSPITALS)

MBCHB UNIVERSITY OF EDINBURGH 2014, FULL MRCP (UK)

DR LUSHEN PILLAY, HEAD OF DERMATOLOGY
MD WITS UNIVERSITY, SOUTH AFRICA

Board of Advisors

Prof Eran Segal

Eran Segal is a Professor at the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science. His group has extensive experience in machine learning, computational biology, and analysis of heterogeneous high-throughput genomic data.

http://genie.weizmann.ac.il

Dr Alexander

Lezhava

Senior Group Leader & Associate Director at Genome Institute of Singapore. Expert in the commercial development of medical diagnostics and clinical-grade molecular assays. Doctor of Philosophy (PhD), Microbiology at Hiroshima University.

Our advisors are world leaders in the skin microbiome and have extensive experience in bringing forward solutions for skin concerns

Dr Natalya Fox

Dr Natalya Fox is a Dermatologist at the NHS - St George's Hospital, London. Previously, Fox did her MBChB at the University of Edinburgh 2014, and has her Full MRCP UK in Dermatology. Fox is passionate about the skin microbiome and its place in dermatology.

Prof. Elena Lurie-Luke

A senior R&D, Innovation and Entrepreneurship Executive with extensive technical, strategic business development. Proven leadership experience in both global FMCG and public health sector environments.

Prof. Niranjan Nagarajan

Associate Director & Senior Group Leader at Genome Institute of Singapore. Expert in computation biology, in particular the study of microbial communities resident on the human skin. Doctor of Philosophy (PhD), Computer Science at Cornell University.

Prof. Tom Dawson

Senior Principal Investigator at Skin Research Institute of Singapore. Over 30 years experience in biotechnology innovations, and expert in the skin and hair microbiome. Doctor of Philosophy (PhD), Pharmacology at University of North Carolina.

Please find listed a selection of relevant peer-reviewed publications from our advisors.

Wu G, TL Dawson, et al. (2015) Genus-Wide Comparative Genomics of Malassezia Delineates Its Phylogeny, Physiology, and Niche Adaptation on Human Skin. PLOS Genetics 11(11): e1005614.
Chng, K., Nagarajan, N., et al. (2016) Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nat Microbiol 1, 16106.
Tay, A.S., Nagarajan, N., et al (2018). 1039 Skin microbiome profiles of atopic dermatitis patients segregate into two community composition types that are stable before and after therapy. Journal of Investigative Dermatology. 138. S176. 10.1016/j.jid.2018.03.1051.
Ramasamy S., Barnard, E., Dawson, TL, and Huiying Li. (2019). Role of the skin microbiota in acne pathophysiology. British Journal of Dermatology, https://doi.org/10.1111/bjd.18230.

Dawson, TL. (2019) Malassezia: The Forbidden Kingdom Opens. Cell Host Microbe https://doi.org/10.1016/j.chom.2019.02.010
Tay, A.S., Nagarajan, N., et al (2020). Atopic dermatitis microbiomes stratify into ecologic dermotypes enabling microbial virulence and disease severity. The Journal of allergy and clinical immunology. 10.1016/j.jaci.2020.09.031.
Dawson, TL. (2021) Malassezia: A Skin Commensal Yeast Impacting Both Health and Disease. Front. Cell. Infect. Microbiol., doi.org/10.3389/fcimb.2021.659219